ARISTOTLE-based Stroke Risk (Appraisal of Risk in AF) Calculator

Clinical calculation support · Verify results before clinical use

Clinical profile

Enter the clinical characteristics below. This version does not calculate a numerical stroke probability because the equation in the supplied source code could not be verified against a published model.

Model not validated

Enter a whole number from 18 to 120.

History of stroke or transient ischemic attack (TIA)

Previous stroke or TIA history.

Hypertension

History or diagnosis of hypertension.

Diabetes mellitus

History or diagnosis of diabetes mellitus.

Heart failure or reduced LVEF

History of heart failure or left ventricular systolic dysfunction.

Clinical context and limitations

The original ARISTOTLE trial evaluated apixaban versus warfarin in patients with atrial fibrillation. A distinct biomarker-based model developed using ARISTOTLE data is the ABC-stroke score (Age, Biomarkers, Clinical history).

The published ABC-stroke model includes age, prior stroke/TIA, NT-proBNP, and high-sensitivity cardiac troponin. It was developed using Cox regression and evaluated for prediction of stroke or systemic embolism. The clinical-only equation in the original Appcardio code is not the published ABC-stroke equation.

Practical use

  • Use an established, appropriately validated stroke-risk assessment for routine clinical decision-making.
  • Consider the applicable AF guideline, bleeding risk, contraindications, patient preferences, and the clinical context when evaluating anticoagulation.
  • Do not interpret the entered profile as a validated risk score or an individualized probability.

References

Hijazi Z, Lindbäck J, Alexander JH, et al.

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. European Heart Journal. 2016;37(20):1582–1590.

doi:10.1093/eurheartj/ehw054 · PMID: 26920728

Oldgren J, Hijazi Z, Lindbäck J, et al.

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation. Circulation. 2016;134(22):1697–1707.

doi:10.1161/CIRCULATIONAHA.116.022802 · PubMed

Granger CB, Alexander JH, McMurray JJV, et al.

Apixaban versus Warfarin in Patients with Atrial Fibrillation. New England Journal of Medicine. 2011;365:981–992.

doi:10.1056/NEJMoa1107039

Clinical disclaimer: This page is a clinical profile interface, not a validated numerical stroke-risk calculator. The risk equation in the supplied source code has been withheld from use because its coefficients and calibration could not be verified. Confirm the intended instrument and validated calculation method before using this tool to guide patient care.